CHICAGO – EVERSANA™, the leading independent provider of global services to the life science industry, today announced three appointments to the executive leadership team. Greg Skalicky, Chief Revenue Officer, Tim Guttman, Chief Financial Officer, and Mark MacNaughton, Chief Information Officer, bring a combined 80 years of life science expertise to EVERSANA, bolstering its position as […]
Posted on February 26, 20192/26/19
- Pricentric Insights: What a Biden Presidency Could Mean for Drug Pricing in the U.S.
- UK’s MHRA Joins ACSS-Consortium, FDA’s Project Orbis
- Mirum Pharmaceuticals Announces Partnership With EVERSANA to Support Launch and Commercialization of Maralixibat for Alagille Syndrome in the United States
- Japan’s Ministry of Health Proposes Finalized Off-Year Re-pricing for All Medicines
- EMA Commences Rolling Review of Second COVID-19 Vaccine